Karmanos Cancer Institute Wins $1.3M Pentagon Grant to Remain in Prostate Cancer Clinical Trials Consortium

Karmanos Cancer Institute Wins $1.3M Pentagon Grant to Remain in Prostate Cancer Clinical Trials Consortium
Detroit’s Barbara Ann Karmanos Cancer Institute has snared a four-year, $1.23 million grant renewal from the U.S. Department of Defense to keep its membership in the prestigious Prostate Cancer Clinical Trials Consortium (PCCTC) program. Karmanos, a member of the consortium since 2008, was one of only seven sites funded this year, down from 11 sites in 2013. Leading the

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *